Evidence map›Paper›PMID 38529351›Full record

ArticleERJ open research2024

ERS International Congress 2023: highlights from the Interstitial Lung Diseases Assembly.

Laura Fabbri, Julien Guiot, Marie Vermant, Ewa Miądlikowska, Deborah Estrella, Marlies S Wijsenbeek, Wim Wuyts, Elena Bargagli, Antoine Froidure, Paolo Spagnolo and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 10 countries.

Laura FabbriMargaret Turner Warwick Centre for Fibrosing Lung Diseases, NHLI, Imperial College, London, UK.
Julien GuiotDepartment of Respiratory Medicine, University Hospital of Liège, Liège, Belgium.
Marie VermantLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Ewa MiądlikowskaDepartment of Pneumology, Medical University of Lodz, Lodz, Poland.
Deborah EstrellaHospital das Clínicas, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Marlies S WijsenbeekCentre for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Wim WuytsLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9648-3497
Elena BargagliRespiratory Diseases Unit, Department Medical Sciences, Surgery and Neurological Sciences, Siena University, Siena, Italy.
Antoine FroidurePulmonology Department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
Paolo SpagnoloRespiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Marcel VeltkampILD Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands.
Maria Molina-MolinaILD Unit, Respiratory Department, University Hospital of Bellvitge, IDIBELL, CIBERES, Barcelona, Spain.
Cormac McCarthyUCD School of Medicine, Education and Research Centre, St Vincent's University Hospital, Dublin, Ireland.ORCID https://orcid.org/0000-0003-2896-5210
Katerina AntoniouLaboratory of Molecular and Cellular Pneumonology, Dept of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.ORCID https://orcid.org/0000-0002-0283-5293
Michael KreuterMainz Center for Pulmonary Medicine, Department of Pneumology, ZfT, Mainz University Medical Center and Department of Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
Catharina C MoorCentre for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5295-2877
Erasmus MC · NLKU Leuven · BEBellvitge University Hospital · ESCliniques Universitaires Saint-Luc · BEGuy's and St Thomas' NHS Foundation Trust · GBJohannes Gutenberg University Mainz · DEMedical University of Lodz · PLSt. Vincent's University Hospital · IEUniversidade Federal de Minas Gerais · BRUniversity Medical Center Utrecht · NLUniversity of Crete · GRUniversity of Liège · BEUniversity of Padua · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article summarises a selection of scientific highlights in the field of interstitial lung diseases (ILDs) presented at the International Congress of the European Respiratory Society in 2023. Translational and clinical studies focused on the whole spectrum of ILDs, from (ultra)rare ILDs to sarcoidosis, ILDs associated with connective tissue disease and idiopathic pulmonary fibrosis. The main topics of the 2023 Congress presentations were improving the diagnostic process of ILDs, better prediction of disease course and investigation of novel treatment options.

Identifiers

PMID38529351
PMCPMC10962449
OpenAlexW4389180803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.